Afamelanotide: all 21 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and VRecruitingNCT05370235Phase 2
- A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)RecruitingNCT05159752Phase 2
- Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria PatientsCompletedNCT06388642Phase 1/2Results posted
- Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)CompletedNCT05854784Phase 2Results posted
- A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)CompletedNCT04962503Phase 2Results posted
- Afamelanotide in Patients Suffering With Acne VulgarisCompletedNCT04943159Phase 2Results posted
- Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)CompletedNCT04704713Phase 3Results posted
- A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)CompletedNCT04578496Phase 3Results posted
- Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)CompletedNCT04525157Phase 2Results posted
- Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer SodiumCompletedNCT04425746Phase 2Results posted
- Multicentre Phase III Erythropoietic Protoporphyria StudyCompletedNCT04053270Phase 3Results posted
- Phase III Confirmatory Study in Erythropoietic ProtoporphyriaCompletedNCT01605136Phase 3Results posted
- Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)CompletedNCT01097044Phase 2Results posted
- Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)CompletedNCT00979745Phase 3Results posted
- DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy VolunteersCompletedNCT05368857Phase 1
- A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the FaceStatus unknownNCT05210582Phase 2
- Implant Pharmacokinetic and Pharmacodynamic StudyCompletedNCT03634137Phase 1
- Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)CompletedNCT01430195Phase 1
- Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental VitiligoCompletedNCT01382589Phase 2
- Phase II Solar Urticaria (SU) Pilot StudyCompletedNCT00859534Phase 2
- Phase II AK Study in Organ Transplant PatientsStatus unknownNCT00829192Phase 2